Cornea and conjunctiva protection

Cornea and conjunctiva protection describes the physiological and therapeutic objective of maintaining the structural and functional health of the eye's outermost layers. It is not a specific molecular target, but rather a multifaceted process supported by the tear film, which comprises lipid, aqueous, and mucin components that collectively provide lubrication and defense against environmental damage (Review of Ophthalmology, 2014). This protection is critical for preserving corneal transparency and visual acuity; when compromised, it leads to conditions such as dry eye syndrome, keratitis, and corneal ulceration (NIH, 2023). Pharmacological interventions aim to restore this protective barrier using agents ranging from lubricating polymers to anti-inflammatory drugs that promote homeostatic recovery (StatPearls, 2023). Therapeutic strategies also include the use of mucinomimetics and secretagogues to enhance the natural production of tear components (PubMed, 2021). Ensuring the integrity of the ocular surface is vital for protecting the eye from mechanical friction during blinking and from chemical or thermal injuries. Consequently, 'cornea and conjunctiva protection' represents a critical clinical outcome in ophthalmology achieved by targeting various pathways that maintain the ocular surface environment.

Other names

Ocular surface protectionCorneal protectionConjunctival lubricationMaintenance of ocular surface homeostasis

Enhancement and replenishment of the tear film layers, provision of a viscoelastic barrier to reduce friction, and stabilization of the ocular surface environment.